# Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children

> **NCT00364104** · PHASE3 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 125 (actual)

## Conditions studied

- Iron Deficiency

## Interventions

- **DRUG:** Quadruple sequential Helicobacter pylori eradication + iron sulfate
- **DRUG:** Quadruple sequential Helicobacter pylori eradication therapy
- **DRUG:** Ferrous sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00364104
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 125 (ACTUAL)
- **Last updated:** 2009-06-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00364104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00364104, "Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00364104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*